Close Menu

People in the News

Sep 14, 2020

GenMark Diagnostics: Brian Mitchell

GenMark Diagnostics said in a filing with the US Securities and Exchange Commission that Brian Mitchell, its senior vice president of operations, is no longer employed by the company.

Sep 11, 2020

Invitae: Kimber Lockhart

Invitae has appointed Kimber Lockhart to its board of directors effective Sept. 10. Lockhart has been chief technology officer at technology-enabled primary care organization One Medical since 2015. From 2009 to 2014, she held various engineering leadership positions at Box, an online file sharing service. Lockhart joined Box in 2009, when it acquired Increo Solutions, a document rendering and collaboration technlogy firm she cofounded and led as CEO.  

Sep 10, 2020

Biofidelity: Heiner Dreismann

Biofidelity has appointed Heiner Dreismann as the firm's chairman. Prior to Biofidelity, Dreismann served as president and CEO of Roche Molecular Systems. He currently serves on the board of several public and private life sciences and healthcare firms in the US, Europe, and Israel. 

Sep 10, 2020

Everlywell: Andy Page

Everlywell, a provider of at-home collection lab tests, has appointed Andy Page as its first president. He will report directly to the firm's CEO and Founder Julia Cheek.

Page is a former president and board member of 23andMe and former president and CFO of Livongo. He left Livongo in 2018 to become the CEO of Caption Health, a venture-backed company that uses artificial intelligence to enable people with no ultrasound experience to perform ultrasound exams quickly and accurately.

Sep 10, 2020

Unilabs: Esther Talboom-Kamp

Unilabs has appointed Esther Talboom-Kamp the company's chief innovation officer. She previously was CEO of Saltro, a diagnostics company based in the Netherlands that was acquired recently by Unilabs. As CIO, Talboom-Kamp will oversee product and service innovation across Unilabs, the Swiss firm said.

Sep 10, 2020

Myriad Genetics: Rashmi Kumar

Myriad Genetics' board of directors has elected Rashmi Kumar, senior VP and global chief information officer at Hewlett Packard, as its new member and appointed her to the audit and finance committee. With the election of Kumar, Myriad's board now has 12 members. Kumar previously worked at McKesson Corporation as senior VP, chief information officer, and US pharmaceutical and global chief data officer. 

Sep 10, 2020

CareDx: Kashif Rathore, Ryan Phan, Sean Grant, and Danielle Scelfo

CareDx has appointed Kashif Rathore as senior VP of digital business, Ryan Phan as VP of lab operations, Sean Grant as VP of strategy and business development, and Danielle Scelfo as VP of market access and health policy.

Rathore joins CareDx from Cerner, where he held various senior leadership roles. In addition to his most recent role as VP of interoperability, Rathore served in the consulting and technology lines of Cerner's businesses. 

Phan joins CareDx from Kaiser Permanente, where he served as managing director and head of regional molecular genetics and cytogenetics laboratories. He has led multiple strategic laboratory expansions and developed and implemented clinical testing programs. 

Grant joins CareDx from Citigroup Global Capital Markets, where he served as a VP in the investment banking healthcare division. At Citigroup, Grant specialized in raising public and private capital and executed a broad range of transactions, including M&A, for many life sciences companies around the world. 

Scelfo joins CareDx from Hologic, where she served as senior director of health policy and reimbursement. She has more than 25 years of health policy and strategic market access experience, including roles at Genomic Health and Adaptive Biotechnologies.

Sep 09, 2020

Bruker: Bonnie Anderson

Bruker has appointed Bonnie Anderson to the firm's board of directors. She is a cofounder of Veracyte and currently serves as the firm's board chairman and CEO. Prior to Veracyte, Anderson spent 18 years at Beckman Coulter.  

Sep 08, 2020

DermTech: Michael Howell

DermTech has appointed Michael Howell as CSO, a role in which he will coordinate research, new product development, and clinical validation efforts. Howell has over twenty years of academic and pharmaceutical industry experience. Prior to joining DermTech, he was the translational research lead for inflammation and autoimmunity at Incyte, driving the strategic expansion of Incyte’s pipeline in dermatology and other immunological disorders. Prior to that, he held various other roles within the pharmaceutical industry at Boehringer Ingelheim, Immune Tolerance Network, and MedImmune/AstraZeneca.
 
Howell also served as a faculty member in the Division of Allergy and Immunology at National Jewish Health. He earned a bachelor of science degree in biology from Messiah College and a doctorate in immunology from West Virginia University School of Medicine.
Sep 03, 2020

NeoGenomics: Scott Reid

NeoGenomics announced Scott Reid has been promoted to vice president of alliances and companion diagnostics. He was previously the head of strategic alliances and CDx in the Pharma Services department at NeoGenomics. Reid has also served as director of business development at Covance and as business development director at Laboratory Corporation of America Clinical Trials.

Sep 03, 2020

NeuroPointDx: Barbara Handelin, Tony Shuber

NeuroPointDx appointed Barbara Handelin and Tony Shuber as new board members. Both have experience in the development and commercialization of new molecular diagnostic tests. Handelin was founding director of the DNA diagnostics lab at Integrated Genetics, now part of Laboratory Corporation of America, and Shuber was chief technology officer and cofounder of Exact Sciences and Predictive Biosciences.

NeuroPointDx said the appointments signal the expansion of its pipeline of diagnostic and precision medicine offerings in autism and other complex brain disorders, including anxiety and depression.

Sep 02, 2020

Immunovia: Peter Schultz-Knappe, Hans Christian Pedersen

Immunovia announced that its CTO Peter Schultz-Knappe has stepped down to pursue other opportunities. Hans Christian Pedersen, Immunovia's VP of business development, will assume Schultz-Knappe's duties and become its VP of strategy and business development.

Pedersen's expanded responsibilities will include business development, pipeline portfolio strategy, and technology strategy. He has more than 16 years of experience working on companion diagnostics development, marketing, and scientific affairs, and he has worked at Unilabs and Agilent Technologies.

Sep 02, 2020

Castle Biosciences: Toby Juvenal, Kristen Oelschlager, Bob Cook, Matthew Goldberg

Castle Biosciences has promoted Toby Juvenal as chief commercial officer, Kristen Oelschlager as chief operations officer, Bob Cook as senior vice president of research and development, and Matthew Goldberg as a medical director.

Juvenal has served as the company's senior VP of sales since January 2018, and previously served as VP of sales and marketing since joining Castle Bio in October 2008. He has more than 28 years of sales, sales management, and managed care experience in the pharmaceutical, biotechnology, and diagnostics industries.

Oelschlager has served as the company's senior VP of clinical operations since January 2018, and previously served as VP of clinical operations from 2013 to 2018. She joined the company as executive director of operations in October 2008, and has more than 15 years of experience in clinical nursing, clinical operations services, and clinical research. 

Cook has served as Castle Bio's VP of research and development since July 2019, previously serving as VP of medical affairs and research and development from April 2018 to July 2019, executive director of research and development from June 2015 to April 2018, and manager of scientific relations from February 2011 to June 2015. 

Goldberg perviously served as an assistant professor in dermatology and pathology at the Icahn School of Medicine at Mount Sinai in New York, and will retain his affiliation as an assistant clinical professor of dermatology. Before joining the Mount Sinai dermatology faculty, Goldberg directed dermatopathology education for the MedStar Georgetown/Washington Hospital Center Dermatology Residency Program.
Sep 01, 2020

Ortho Clinical Diagnostics: Chris Smith, David Perez

Ortho Clinical Diagnostics has appointed its CEO Chris Smith as chairman of the company's board, effective Sept. 1. He succeeds Robert Yates, who will remain as a member of the board. Additionally, Ortho appointed David Perez as an independent member of the board. He is the former president and CEO of Terumo BCT, a biomedical company focused on blood and cell-based therapies.

Aug 27, 2020

Biocept: Michael Dugan

Biocept has appointed Michael Dugan as chief medical officer and medical director, responsible for medical policy decision-making and operations of Biocept's CLIA-certified laboratory. Dugan has more than 25 years of industry experience, most recently as president and CEO of professional advisory group practice MCDXI Medical Diagnostics International. Before that, he was senior medical advisor and chief medical officer of Clinical Genomics. He has also served as senior VP of clinical development and medical affairs at Exact Sciences, medical director at Quest Diagnostics Nichols Institute, chief medical officer at BioTheranostics, VP and chief medical officer at Roche Molecular Systems, and VP of pathology services at Genzyme Genetics.

Dugan received a BS in biology from the University of Notre Dame and a medical degree from the University of Arizona College of Medicine. He completed his post-graduate training in the department of pathology at Yale-New Haven Hospital and in the departments of pathology and laboratory medicine at Childrens Hospital Los Angeles and the University of California, Los Angeles.

Aug 27, 2020

Oncocyte: Jennifer Levin Carter

Oncocyte has appointed Jennifer Levin Carter to its board of directors. Carter is a healthcare executive, board member, and entrepreneur and was most recently VP and head of precision health at Integral Health. She has founded and served as CEO at healthcare companies including N-of-One, where she was CEO from 2008 to 2012 and chief medical officer from 2012 until its acquisition by Qiagen in 2019. In addition to her board appointment for Oncocyte, Carter serves as a director of DFP Healthcare Acquisitions and is on the board of directors of home healthcare firm HouseWorks, digital health company eCaring, and the Target Cancer Foundation. She is a founding strategic board member of XSphera Biosciences, and on the directors advisory board at Smilow Cancer Hospital at Yale University. 

Aug 27, 2020

Lucence: Chao Xie

Singapore-based precision oncology company Lucence has appointed Chao Xie as chief data scientist to develop advanced analytics of ultrasensitive liquid biopsy diagnostics for cancer. Xie previously served as head of data science at AirAsia. He won a US Defense Threat Reduction Agency $1M global competition in 2013 for designing an algorithm to rapidly and accurately identify dangerous viruses and bacteria in gene sequencing data.

Aug 26, 2020

Immunovia: Patrik Dahlen and Mats Grahn

Immunovia appointed Patrik Dahlen as its new CEO starting Nov. 1. Dahlen succeeds Mats Grahn, who has been nominated as a member of Immunovia's board.

Dahlen has served as CEO of several diagnostic companies. As CEO of Dako, he implemented a strategic repositioning of the company as a supplier of cancer diagnostics, which resulted in its acquisition by Agilent Technologies for $2.2 billion. As president of life sciences at Perkin Elmer, he was instrumental in building the company's diagnostics business with a niche focus on diagnostic systems for neonatal and prenatal screening.

Aug 25, 2020

Illumina: Kathryne Reeves

Illumina has announced that Kathryne Reeves will join the firm as chief marketing officer on Sept. 28, 2020, reporting to CEO Francis deSouza.

Reeves brings more than 25 years of marketing and management experience and comes to Illumina from Cardinal Health, where she was senior VP of enterprise marketing and general manager of the medical services global business unit. Prior to that, she held positions at Booz Allen Hamilton, AOL/TimeWarner, Nationwide Insurance, and Scotts Miracle-Gro.

Reeves holds an MBA from Harvard Business School.

Aug 24, 2020

AusDiagnostics: Scott Gilroy

AusDiagnostics appointed Scott Gilroy as its new CEO, effective Aug. 24. Gilroy was previously chief operations officer at the company and will take over from Keith Stanley, who will serve as managing director. Gilroy has served in many positions at Malvern Panalytical, including as the general manager for the Australia/New Zealand and Oceania division, regional head of sales and marketing for Asia Pacific, and national sales and marketing manager. 

Aug 21, 2020

Qiagen: Lawrence Rosen

Qiagen has appointed Lawrence Rosen as the chairman of the firm's supervisory board. He will replace Håkan Björklund, who will step down as chairman and as a member of Qiagen's supervisory board. 

Rosen currently has served as a member of Qiagen's supervisory board since 2013. He also serves on the supervisory board of German firm Lanxess. Rosen previously served as a member of the board of management and CFO at Deutsche Post DHL Group until 2016. Prior to that, he held the role of CFO of Fresenius Medical Care from 2003 to 2009. Prior to Fresenius Medical Care, Rosen was senior VP and treasurer for Aventis. Between 1984 and 2000, he held various positions at Avenis predecessor companies Hoechst and American Hoechst/Hoechst Celanese. 

Aug 18, 2020

Becton Dickinson: Kristen Stewart

Becton Dickinson has appointed Kristen Stewart to the newly created position of Senior Vice President of Strategy and Investor Relations, reporting to BD's CFO Chris Reidy. Stewart will work with the BD executive team beginning Aug. 31 to drive shareholder value and to deliver and communicate the company's long-term growth strategy, BD said in a statement. Stewart has worked with investment banks for nearly two decades as a healthcare analyst specializing in medical technology, most recently leading the medical technology research division at Barclays Capital.

Aug 18, 2020

Alveo Technologies: Julianne Averill

Infectious disease diagnostic firm Alveo Technologies recently announced the appointment of Julianne Averill as CFO. She will be responsible for leading all financial operations and implementing strategies to accelerate Alveo's growth, the company said in a statement. Averill has 18 years of leadership experience and most recently served as VP of Finance for BlackThorn Therapeutics. Before that, she held leadership positions at Manifest MedEx and Starwood Waypoint Residential Trust and served as an audit manager at Deloitte. Averill has also participated in or led strategic financing and M&A initiatives totaling more than $2 billion. 

Aug 18, 2020

SQI Diagnostics: Robert Chioini

SQI Diagnostics has appointed Robert Chioini its CEO and a company director, effective Aug. 17. Chioini funded Rockwell Medical and served as its chairman and CEO from 1995 to 2018. He has more than 30 years of operational and business development experience in the medical industry. Eric Brouwer, who had been SQI's interim CEO, will continue as CSO and a director at the company.

Aug 18, 2020

Bionano Genomics: Alka Chaubey

Bionano Genomics has appointed Alka Chaubey as its first chief medical officer, effective Aug. 31, 2020.

Chaubey, a cytogeneticist, will be responsible for driving adoption of the firm's Saphyr optical genome mapping platform for use in clinical applications.

She brings nearly 20 years of scientific and clinical experience and has developed and validated clinical tests, including US Food and Drug Administration-cleared whole-genome cyotgenetic tests. She comes to Bionano from PerkinElmer, where she is head of the cytogenomics. She is also an adjunct assistant professor of pathology at the Medical College of Georgia at Augusta University and is scientific director of the Georgia Esoteric and Molecular Laboratory and the Augusta University Medical Center cytogenetics laboratory. Before coming to PerkinElmer, she directed the Greenwood Genetic Center's cytogenomics laboratory.

Chaubey holds a doctorate in biochemistry and molecular biology from India's Guru Nanak Dev University.

Pages